Merck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive agreement to acquire Mirus Bio in a $600m (€500m) deal. The move aims to enhance Merck’s ...

BURLINGTON, Mass.--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, and Opentrons Labworks, Inc., a leader in lab automation and ...

The NIIMBL supported training network is in its pilot stage and includes UMass Lowell, UMass Dartmouth, Mass Biologics, and MIT with industry input from Merck & Co., Pfizer, and Millipore Sigma. The ...

Merck KGaA, known as MilliporeSigma in the United States and Canada, is a significant player in the Industrial Asia Pacific Bioprocess Technology Market. The company offers a wide range of bioprocess ...